Rejuvenate Bio

CLOSING THIS WEEK: Reversing decline — proven in animals, advancing to humans

https://wefunder.com/rejuvenatebio

Total raised on Wefunder: 3200000

Total investors: 1437

Quick facts

  • Just closed a $6M round backed by Merck Animal Health and top-tier VCs
  • Co-founded by George Church, Harvard Medical School geneticist and TIME 100 scientist
  • $130M+ in contracted development & commercial milestone payments across 6 animal health partnerships
  • $5.1M in cumulative payments and in-kind services received from partners
  • One-time injection gives years of treatment, with 2+ years of effect shown in dogs
  • Radically cut manufacturing costs 10x to make doses accessible at $100/dose
  • $250B+ market opportunity in the aging, metabolic & cardiac disease market

Team profiles

Featured investor profiles

Invest in Rejuvenate Bio

CLOSING THIS WEEK: Reversing decline — proven in animals, advancing to humans

Closing on Oct 30 @ 11:59 PM ET
--
day
--
hour
--
min
--
sec
Oversubscribed

$10,364,015

raised from 1,450+ investors
INVESTMENT TERMS
Preferred Stock
$59.4M pre-money valuation $0.91 per share
Posts